About 22,045 results

ALLMedicine™ Hysterectomy Center

Research & Reviews  7,256 results

Gestational trophoblastic neoplasm in a patient with end-stage renal failure (ESRF): th...
BMJ Case Reports; Loo KCY, Lim YN et. al.

May 19th, 2022 - Gestational trophoblastic neoplasm (GTN) in end-stage renal failure (ESRF) has not been reported. We reported an unprecedented case of GTN in ESRF from an antecedent partial mole. She had total abdominal hysterectomy and bilateral salpingectomy fo...

Retained products of conception (RPOC) following delivery without placenta previa: Whic...
Placenta Takahashi H, Tanaka H et. al.

May 18th, 2022 - To clarify the perinatal outcome of retained products of conception (RPOC) after 22 weeks or more. The retrospective cohort study reviewed medical records of patients with RPOC without placenta previa at 186 Japanese perinatal centers. Of the 323 ...

Predictors of same-day discharge following benign minimally invasive hysterectomy.
American Journal of Obstetrics and Gynecology; Hong CX, Kamdar NS et. al.

May 18th, 2022 - Same-day discharge (SDD) following minimally invasive hysterectomy (MIH) has been shown to be safe and feasible in select populations, but many non-clinical factors influencing SDD remain unexplored. To develop prediction models for SDD following ...

Endometrial Cancer Treatment Protocols

May 18th, 2022 - Treatment Protocols Treatment protocols for endometrial cancer are provided below, including the following: General treatment recommendations Recommendations for limited, metastatic, recurrent, and high-risk disease Risk classifications General tr...

Metastatic follicular carcinoma arising from struma ovarii.
BMJ Case Reports; Deng J, Ng YHG et. al.

May 18th, 2022 - Struma ovarii (SO) is an uncommon monodermal teratoma predominantly composed of mature thyroid tissue. Approximately 5% of SO are malignant; however, metastases are rare. A single female in her 40s, with a medical history of Graves' disease and bi...

see more →

Guidelines  31 results

Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
Obstetrics and Gynecology;

May 21st, 2021 - Uterine leiomyomas (fibroids) are the most common solid and symptomatic neoplasm in women. They are the leading indication for hysterectomy (1, 2), which is a definitive and effective surgical treatment for leiomyoma. However, many patients benefi...

Should we perform cervix removal during hysterectomy for benign uterine disease? Clinic...
Journal of Gynecology Obstetrics and Human Reproduction; Millet P, Gauthier T et. al.

Apr 2nd, 2021 - To provide guidelines from the French College of Obstetricians and Gynecologists (CNGOF), based on the best evidence available, concerning subtotal or total hysterectomy, for benign disease. The CNGOF has decided to adopt the AGREE II and GRADE sy...

Uterine Morcellation for Presumed Leiomyomas: ACOG Committee Opinion, Number 822.
Obstetrics and Gynecology;

Feb 18th, 2021 - Morcellation is a surgical technique used to reduce the size of the uterus or myomas by creating smaller pieces to allow the tissue to be removed through small incisions or with laparoscopic instruments. Open (uncontained) morcellation of the uter...

Robot-Assisted Surgery for Noncancerous Gynecologic Conditions: ACOG COMMITTEE OPINION,...
Obstetrics and Gynecology;

Aug 23rd, 2020 - For noncancerous conditions, such as hysterectomy, a minimally invasive approach to gynecologic surgery has well-documented advantages-including faster return to normal activities, decreased length of stay, and better quality of life-compared with...

Cervical cancer screening for individuals at average risk: 2020 guideline update from t...
CA: a Cancer Journal for Clinicians; Fontham ETH, Wolf AMD et. al.

Jul 31st, 2020 - The American Cancer Society (ACS) recommends that individuals with a cervix initiate cervical cancer screening at age 25 years and undergo primary human papillomavirus (HPV) testing every 5 years through age 65 years (preferred); if primary HPV te...

see more →

Drugs  59 results see all →

Clinicaltrials.gov  402 results

Effectiveness of a Nursing Intervention on Quality of Life, Sexual Function, and Self-esteem in Hysterectomized Women

May 13th, 2022 - TITLE: Effectiveness of a nursing educational intervention on quality of life, sexual function and self-esteem in hysterectomized women: a mixed-method approach. 1.1 PRESENTATION AND RATIONALE OF THE PROBLEM The 20th century has been decisive for ...

Same Day Discharge After Laparoscopic Hysterectomy

May 13th, 2022 - Patients who are scheduled for laparoscopic hysterectomy will be included in the study. After the operation, those who are well and without major distress will be discharged from the hospital before 24 hours. Those who have pain or have additional...

Study to Assess the Safety and Efficacy of the IUB SEAD™ Device

May 12th, 2022 - Chronic abnormal uterine bleeding (AUB), involving menstrual bleeding of abnormal quantity, duration, or schedule, is experienced by 10-35% of women, and can markedly impact everyday activities, can lead to iron deficiency and in severe cases, can...

Uterine Transplantation for the Treatment of Uterine Factor Infertility

May 6th, 2022 - Uterine factor infertility (UFI) is one of the few irreversible causes of female infertility. Until recently, no medical or surgical options have been available for women with this diagnosis. UFI is defined by the lack of a functional uterus; this...

Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study

May 4th, 2022 - The researchers aim to determine whether use of etonogestrel implant in patients with failed endometrial ablation significantly decreases hysterectomy rate. Changes in pelvic pain and vaginal bleeding will be assessed. Time to hysterectomy will be...

see more →

News  1,056 results

Sexual Minorities Less Likely to Receive Pap Screening

May 17th, 2022 - NEW YORK (Reuters Health) - Sexual minorities who have a cervix are less likely than heterosexual women to be screened for cervical cancer, a new study suggest. An analysis of data from more than 18,000 people who were assigned female sex at birth...

Concurrent Durvalumab/Chemoradiation Misses PFS End Point in Locally Advanced Cervical Cancer

Apr 20th, 2022 - Durvalumab (Imfinzi) given concurrently with chemoradiation was not found to significantly improve progression-free survival (PFS) vs chemoradiation alone in patients with locally advanced cervical cancer, missing the primary end point of the phas...

Removing Fallopian Tubes During Hysterectomy May Curb Ovarian Cancer Risk

Feb 22nd, 2022 - NEW YORK (Reuters Health) - Removal of the fallopian tubes during hysterectomy or instead of tubal ligation, a procedure known as opportunistic salpingectomy (OS), was associated with fewer serous and epithelial ovarian cancers than expected in a ...

Researchers identify growing racial disparity in endometrial cancer mortality
Jeff Craven

Feb 10th, 2022 - Women in the United States are less likely to die of ovarian cancer, but more likely to die of endometrial cancer than they were 3 decades ago, according to a recent research letter published in Obstetrics & Gynecology. “This convergence is becaus.

Cervical Cancer Screening Rates on the Decline in the US

Jan 19th, 2022 - The number of women screened for cervical cancer in the United States declined between 2005 and 2019 with lack of knowledge about the need for screening being cited as the most common reason for not receiving up-to-date screening. These are the re...

see more →

Patient Education  14 results see all →